In the study of Zeijlemaker et al., the expression of CD2 was detected in 18% of AML patients, in which the BM samples of 236 AML patients were subjected to flow cytometric immunophenotyping [37]. The gene discussed is CD2; the disease is acute myeloid leukemia.